Seeing Is Believing
AKRO is currently covered by 9 analysts with an average price target of $49.66. This is a potential upside of $21.54 (76.6%) from yesterday's end of day stock price of $28.12.
Akero Therapeutics's activity chart (see below) currently has 31 price targets and 52 ratings on display. The stock rating distribution of AKRO is 9.38% HOLD and 90.63% BUY.
Analysts average stock forecasts to be materialized ratio is 33.32% with an average time for these price targets to be met of 241 days.
Highest price target for AKRO is $56, Lowest price target is $33, average price target is $49.66.
Most recent stock forecast was given by PRAKHAR AGRAWAL from CANTOR FITZGERALD on 20-Jun-2024. First documented stock forecast 15-Jul-2019.
Currently out of the existing stock ratings of AKRO, 3 are a HOLD (9.38%), 29 are a BUY (90.63%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
1 months 6 days ago
0/3 (0%)
$23.96 (159.31%)
Buy
50
$23.24 (86.85%)
50
1 months 15 days ago
2/18 (11.11%)
$26.57 (113.40%)
495
Buy
38
$11.24 (42.00%)
60
2 months 11 days ago
1/3 (33.33%)
$16.93 (80.35%)
106
Buy
56
$29.24 (109.27%)
59
2 months 13 days ago
4/7 (57.14%)
$35.38 (171.58%)
496
Buy
39
$12.24 (45.74%)
83
9 months 14 days ago
0/2 (0%)
$24.31 (165.49%)
What is AKRO (Akero Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on AKRO (Akero Therapeutics) with a proven track record?
Which analyst has the current lower performing score on AKRO (Akero Therapeutics) with a proven track record?
Which analyst has the most public recommendations on AKRO (Akero Therapeutics)?
Which analyst is the currently most bullish on AKRO (Akero Therapeutics)?
Which analyst is the currently most reserved on AKRO (Akero Therapeutics)?